Aluminum Leaching from Fluid Warmers: Regulatory Deferral to Clinicians' Decision.


Journal

Biomedical instrumentation & technology
ISSN: 0899-8205
Titre abrégé: Biomed Instrum Technol
Pays: United States
ID NLM: 8905560

Informations de publication

Date de publication:
01 Apr 2022
Historique:
entrez: 6 5 2022
pubmed: 7 5 2022
medline: 11 5 2022
Statut: ppublish

Résumé

Fluid-warming systems are crucial in surgical and trauma settings because of their key role in preventing or treating hypothermia and enabling proper resuscitation of blood products that are stored cold. Recently, several manufacturers have issued warnings of the possibility of aluminum leaching from their fluid warmers and cautioned about the potential for aluminum toxicity in patients who underwent fluid resuscitation with these devices. Studies suggest that one of the main factors affecting aluminum leaching in this setting is the coating of the aluminum plate itself. Coating, often with a biocompatible material, appears to reduce aluminum leaching by 100- to 200-fold compared with an uncoated plate. Nonetheless, leaching with the coating is still at a level exceeding U.S. regulations. A few aluminum-free warming systems are available on the market, but these are not carried by all providers and some clinicians may be less familiar with their use. Medical device manufacturers will likely design future warming systems with less potential for aluminum blood contact. In the meantime, the risk of inadequate resuscitation, consequent to the proper fluid warmer no longer being available, is contrasted with the risk of potential toxicity. In the situation described here, the regulators deferred the ultimate decision of which fluid warmer to use in a given situation to the risk-benefit decision of the clinician.

Identifiants

pubmed: 35522920
pii: 481648
doi: 10.2345/1943-5967-56.2.37
pmc: PMC9767429
doi:

Substances chimiques

Aluminum CPD4NFA903

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-40

Informations de copyright

© Copyright AAMI 2022 Copying, networking, and distribution prohibited.

Références

Fed Regist. 1998 Jan 5;63(2):176-85
pubmed: 10176836
Anaesthesia. 2019 Jun;74(6):708-713
pubmed: 30793280
BMC Anesthesiol. 2021 May 27;21(1):163
pubmed: 34044771
Anesth Prog. 2010 Spring;57(1):25-32; quiz 33-4
pubmed: 20331336
BMC Anesthesiol. 2018 Jul 28;18(1):98
pubmed: 30055566
Anaesthesia. 2019 Nov;74(11):1354-1356
pubmed: 31297796
Anaesthesia. 2019 Nov;74(11):1374-1380
pubmed: 31066048

Auteurs

Marko Oydanich (M)

Marko Oydanich, MS, is a medical student at Rutgers New Jersey Medical School in Newark, NJ. Email: mko36@gsbs.rutgers.edu.

Rotem Naftalovich (R)

Rotem Naftalovich, MD, MBA, is head of neurosurgical anesthesia at Rutgers New Jersey Medical School in Newark, NJ, and a Captain in the Medical Corps of the U.S. Army, Fort Sam Houston, TX. Email: naftalro@njms.rutgers.edu.

Patrick J Discepola (PJ)

Patrick J. Discepola, MD, is the director of regional anesthesia at Rutgers New Jersey Medical School in Newark, NJ. Email: disceppj@njms.rutgers.edu.

Jim Doran (J)

Jim Doran, CRNA, is a clinical instructor at Rutgers New Jersey Medical School and the chief CRNA at University Hospital in Newark, NJ. Email: doranja@uhnj.org.

Faraz A Chaudhry (FA)

Faraz Chaudhry, MD, is the director of clinical operations at Rutgers New Jersey Medical School in Newark, NJ. Email: chaudhfa@njms.rutgers.edu.

Daniel J Eloy (DJ)

Jean Daniel Eloy, MD, is vice-chair for clinical research at Rutgers New Jersey Medical School in Newark, NJ. Email: eloyje@njms.rutgers.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH